TY  - GEN
AU  - Gaudio,Eugenio
AU  - Tarantelli,Chiara
AU  - Ponzoni,Maurilio
AU  - Odore,Elodie
AU  - Rezai,Keyvan
AU  - Bernasconi,Elena
AU  - Cascione,Luciano
AU  - Rinaldi,Andrea
AU  - Stathis,Anastasios
AU  - Riveiro,Eugenia
AU  - Cvitkovic,Esteban
AU  - Zucca,Emanuele
AU  - Bertoni,Francesco
TI  - Bromodomain inhibitor OTX015 (MK-8628) combined with targeted agents shows strong in vivo antitumor activity in lymphoma
SN  - 1949-2553
PY  - 2018///0223
KW  - Acetanilides
KW  - pharmacology
KW  - Adenine
KW  - analogs & derivatives
KW  - Agammaglobulinaemia Tyrosine Kinase
KW  - Animals
KW  - Antineoplastic Agents
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Cell Line, Tumor
KW  - Drug Synergism
KW  - Everolimus
KW  - Heterocyclic Compounds, 3-Ring
KW  - Histone Deacetylase Inhibitors
KW  - Humans
KW  - Hydroxamic Acids
KW  - Lymphoma, Large B-Cell, Diffuse
KW  - drug therapy
KW  - Mice
KW  - Mice, Inbred NOD
KW  - Mice, SCID
KW  - Molecular Targeted Therapy
KW  - methods
KW  - Piperidines
KW  - Protein Kinase Inhibitors
KW  - Protein-Tyrosine Kinases
KW  - antagonists & inhibitors
KW  - Pyrazoles
KW  - Pyrimidines
KW  - Rituximab
KW  - TOR Serine-Threonine Kinases
KW  - Vorinostat
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.18632/oncotarget.10983
ER  -